Harnessing (64)Cu/(67)Cu for a theranostic approach to pretargeted radioimmunotherapy

Over the past decade, theranostic imaging has emerged as a powerful clinical tool in oncology for identifying patients likely to respond to targeted therapies and for monitoring the response of patients to treatment. Herein, we report a theranostic approach to pretargeted radioimmunotherapy (PRIT) b...

Descripción completa

Detalles Bibliográficos
Autores principales: Keinänen, Outi, Fung, Kimberly, Brennan, James M., Zia, Nicholas, Harris, Matt, van Dam, Ellen, Biggin, Colin, Hedt, Amos, Stoner, Jon, Donnelly, Paul S., Lewis, Jason S., Zeglis, Brian M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2020
Materias:
Biological Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7668034/
https://www.ncbi.nlm.nih.gov/pubmed/33106429
http://dx.doi.org/10.1073/pnas.2009960117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7668034/
https://www.ncbi.nlm.nih.gov/pubmed/33106429
http://dx.doi.org/10.1073/pnas.2009960117

Ejemplares similares